Retinal Vein Occlusion

Management of CRVO/BRVO.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)

Last reviewed: 21 October 2025

Ophthalmology

Clinical Guidelines

Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA)

NICE Technology Appraisal Guidance [TA1004]: Faricimab (Vabysmo) for treating visual impairment caused by macular oedema after retinal vein occlusion

NICE technology appraisal guidance [TA1004]: Faricimab for treating visual impairment caused by macular oedema after retinal vein occlusion

NICE technology appraisal guidance [TA283]: Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion

NICE Technology Appraisal Guidance [TA283]: Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion

NICE Technology Appraisal Guidance [TA409]: Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion

Retinal Vein Occlusion (RVO) Guidelines – The Royal College of Ophthalmologists

Retinal Vein Occlusion Management Guidelines (NHS Scotland)

The Royal College of Ophthalmologists: Retinal Vein Occlusion (RVO) Guidelines

Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA)

Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA) (PDF)

Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus

Retinal vein occlusion - College of Optometrists Clinical Management Guidelines

Retinal Vein Occlusion (RVO) Guidelines - The Royal College of Ophthalmologists

Retinal Vein Occlusion (RVO) Guidelines (2022) - The Royal College of Ophthalmologists

Retinal Vein Occlusions PPP 2024 - American Academy of Ophthalmology

Retinal Vein Occlusions Preferred Practice Pattern® (2019) - American Academy of Ophthalmology